Loading...
HomeMy WebLinkAboutExhibit 1PROFESSIONAL SERVICES AGREEMENT This Agreement is entered into this _ day of , 200 by and between the City of Miami, a municipal corporation of the State of Florida ("City") and Mercy Medical Development d/b/a Mercy utpatient Center ("Provider"), a Florida not-for-profit corporation. RECITAL A. The City has issued a Request for Proposals ("RFP") for the provision of drug screening services ("Services"), Part I Services: Employment Drug Screening Services and Reasonable Suspicion Drug and Alcohol Screening Services for General Employees (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services); Part H Services: Sworn Fire Drug and Alcohol Screening Services (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services); Part III Services: DOT Drug and Alcohol Screening Services (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services); Part IV Random and Reasonable Suspicion Drug and Alcohol Screening Services for AFSCME, Local 871 Employees (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services); and Part V Services: Sworn Police Drug and Alcohol Screening Services (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services), and Provider's proposal ("Proposal"), in response thereto, Mercy Medical Development d/b/a Mercy Outpatient Center, has been selected as the most qualified proposal for the provision of Part I: Employment Drug Screening Services and Reasonable Suspicion Drug and Alcohol Screening Services for General Employees (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services), for the provision of Part H: Sworn Fire Drug and Alcohol Screening Services (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services), for the provision of Part IV: Random and Reasonable Suspicion pw—fil— clIq - I qq Drug and Alcohol Screening Services for AFSCME, Local 871 Employees (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services), and for the provision of Part V Services: Sworn Police Drug and Alcohol Screening Services (A. Collection Facility, B. Drug Testing Facility, and C. MRO Services). The RFP and the Proposal are sometimes referred to herein, collectively, as the Solicitation Documents, and are by this reference incorporated into and made a part of this Agreement. B. The Commission of the City of Miami, by Resolution No. , adopted on , approved the selection of Provider and authorized the City Manager to execute a contract, under the terms and conditions set forth herein. NOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, Provider and the City agree as follows: TERMS 1. RECITALS: The recitals are true and correct and are hereby incorporated into and made apart of this Agreement. 2. TERM: The term of this Agreement shall be for an initial two (2) year periods commencing on the effective date hereof. 3. OPTION TO EXTEND: The City shall have three option(s) to extend the term hereof for a period of one year each, subject to availability and appropriation of funds. The City shall exercise its right to extend the term hereof by giving Provider thirty (30) days written notice prior to the expiration of the previous term. City Commission approval shall not be required as long as the total extended term does not exceed three (3) years. 4. SCOPE OF SERVICE: CoM: PSA & Corp Reso Mercy Drug Testing 2009 2 A. Provider agrees to provide the Services as specifically, described, and under the special terms and conditions set forth in Attachment "A" hereto, which by this reference is incorporated into and made a part of this Agreement. B. Provider represents and warrants to the City that: (i) it possesses all qualifications, licenses and expertise required under the Solicitation Documents for the performance of the Services; (ii) it is not delinquent in the payment of any sums due the City, including payment of permit fees, occupational licenses, etc., nor in the performance of any obligations to the City; (iii) all personnel assigned to perform the Services are and shall be, at all times during the term hereof. fully qualified and trained to perform the tasks assigned to each; and (iv) the Services will be performed in the manner described in Attachment "A". 5. COMPENSATION: A. The amount of compensation payable by the City to Provider shall be based on the rates and schedules described in Attachment `B" hereto, which by this reference is incorporated into this Agreement. B. Unless otherwise specifically provided in Attachment "B", payment shall be made within forty-five (45) days after receipt of Provider's invoice, which shall be accompanied by sufficient supporting documentation and contain sufficient detail, to allow a proper audit of expenditures, should City require one to be performed. If Provider is entitled to reimbursement of travel expenses (i.e. Attachment "B" includes travel expenses as a specific item of compensation), then all bills for travel expenses shall be submitted in accordance with Section 112.061, Florida Statutes. CoM: PSA & Corp Reso Mercy Drug Testing 2009 3 6. OWNERSHIP OF DOCUMENTS: Provider understands and agrees that any information, document, report or any other material whatsoever which is given by the City to Provider or which is otherwise obtained or prepared by Provider pursuant to or under the terms of this Agreement is and shall at all times remain the property of the City. Provider agrees not to use any such information, document, report or material for any other purpose whatsoever without the written consent of City, which may be withheld or conditioned by the City in its sole discretion. 7. AUDIT AND INSPECTION RIGHTS: A. The City may, at reasonable times, and for a period of up to three (3) years following the date of final payment by the City to Provider under this Agreement, audit, or cause to be audited, those books and records of Provider which are related to Provider's performance under this Agreement. Provider agrees to maintain all such books and records at its principal place of business for a period of three (3) years after final payment is made under this Agreement. B. The City may, at reasonable times during the term hereof, inspect Provider's facilities and perform such tests, as the City deems reasonably necessary, to determine whether the goods or services required to be provided by Provider under this Agreement conform to the terms hereof and/or the terms of the Solicitation Documents, if applicable. Provider shall make available to the City all reasonable facilities and assistance to facilitate the performance of tests or inspections by City representatives. All tests and inspections shall be subject to, and made in accordance with, the provisions of Section 18-100 and 18-101 of the Code of the City of Miami, Florida, as same may be amended or supplemented, from time to time. CoM: PSA & Corp Reso Mercy Drug Testing 2009 4 8. AWARD OF AGREEMENT: Provider represents and warrants to the City that it has not employed or retained any person or company employed by the City to solicit or secure this Agreement and that it has not offered to pay, paid, or agreed to pay any person any fee, commission, percentage, brokerage fee, or gift of any kind contingent upon or in connection with, the award of this Agreement. 9. PUBLIC RECORDS: Provider understands that the public shall have access, at all reasonable times, to all documents and information pertaining to City contracts, subject to the provisions of Chapter 119, Florida Statutes, and agrees to allow access by the City and the public to all documents subject to disclosure under applicable law. Provider's failure or refusal to comply with the provisions of this section shall result in the immediate cancellation of this Agreement by the City. 10. COMPLIANCE WITH FEDERAL STATE AND LOCAL LAWS: Provider understands that agreements between private entities and local governments are subject to certain laws and regulations, including laws pertaining to public records, conflict of interest, record keeping, etc. City and Provider agree to comply with and observe all applicable laws, codes and ordinances as they may be amended from time to time. 11. INDEMNIFICATION: Provider shall indemnify, defend and hold harmless the City and its officials, employees and agents (collectively referred to as "Indemnitees") and each of them from and against all loss, costs, penalties, fines, damages, claims, expenses (including attorney's fees) or liabilities (collectively referred to as "Liabilities") by reason of any injury to or death of any person or damage to or destruction or loss of any property arising out of, resulting from, or in connection with (i) the performance or non-performance of the services contemplated by this Agreement which is or is alleged to be directly or indirectly caused, in whole or in part, by CoM: PSA & Corp Reso Mercy Drug Testing 2009 5 any act, omission, default or negligence (whether active or passive) of Provider or its employees, agents or subcontractors (collectively referred to as "Provider"), regardless of whether it is, or is alleged to be, caused in whole or part (whether joint, concurrent or contributing) by any act, omission, default or negligence (whether active or passive) of the Indemnitees, or any of them or (ii) the failure of the Provider to comply with any of the paragraphs herein or the failure of the Provider to conform to statutes, ordinances, or other regulations or requirements of any governmental authority, federal or state, in connection with the performance of this Agreement. Provider expressly agrees to indemnify and hold harmless the Indemnitees, or any of them, from and against all liabilities which may be asserted by an employee or former employee of Provider, or any of its subcontractors, as provided above, for which the Provider's liability to such employee or former employee would otherwise be limited to payments under state Workers' Compensation or similar laws. 12. DEFAULT: If Provider fails to comply with any term or condition of this Agreement, or fails to perform any of its obligations hereunder, then Provider shall be in default. Upon the occurrence of a default hereunder the City, in addition to all remedies available to it by law, may immediately, upon written notice to Provider, terminate this Agreement whereupon all payments, advances, or other compensation paid by the City to Provider while Provider was in default shall be immediately returned to the City. Provider understands and agrees that termination of this Agreement under this section shall not release Provider from any obligation accruing prior to the effective date of termination. Should Provider be unable or unwilling to commence to perform the Services within the time provided or contemplated herein, then, in addition to the foregoing, Provider shall be liable to the City for all expenses incurred by the City in preparation and CoM: PSA & Corp Reso Mercy Drug Testing 2009 negotiation of this Agreement, as well as all costs and expenses incurred by the City in the re - procurement of the Services, including consequential and incidental damages. 13. RESOLUTION OF CONTRACT DISPUTES: Provider understands and agrees that all disputes between Provider and the City based upon an alleged violation of the terms of this Agreement by the City shall be submitted to the City Manager for his/her resolution, prior to Provider being entitled to seek judicial relief in connection therewith. In the event that the amount of compensation hereunder exceeds $25,000, the City Manager's decision shall be approved or disapproved by the City Commission. Provider shall not be entitled to seek judicial relief unless: (i) it has fust received City Manager's written decision, approved by the City Commission if the amount of compensation hereunder exceeds $25,000, or (ii) a period of sixty (60) days has expired, after submitting to the City Manager a detailed statement of the dispute, accompanied by all supporting documentation (ninety (90) days if City Manager's decision is subject to City Commission approval); or (iii) City has waived compliance with the procedure set forth in this section by written instruments, signed by the City Manager. 14. CITY'S TERMINATION RIGHTS: A. The City shall have the right to terminate this Agreement, in its sole discretion, at any time, by giving written notice to Provider at least five (5) business days prior to the effective date of such termination. In such event, the City shall pay to Provider compensation for services rendered and expenses incurred prior to the effective date of termination. In no event shall the City be liable to Provider for any additional compensation, other than that provided herein, or for any consequential or incidental damages. B. The City shall have the right to terminate this Agreement, without notice to Provider, upon the occurrence of an event of default hereunder. In such event, the City shall not COM: PSA & Corp Reso Mercy Drug Testing 2009 7 be obligated to pay any amounts to Provider and Provider shall reimburse to the City all amounts received while Provider was in default under this Agreement. 15. INSURANCE: Provider shall, at all times during the term hereof, maintain such insurance coverage as may be required by the City. All such insurance, including renewals, shall be subject to the approval of the City for adequacy of protection and evidence of such coverage shall be furnished to the City on Certificates of Insurance indicating such insurance to be in force and effect and providing that it will not be canceled during the performance of the services under this contract without thirty (30) calendar days prior written notice to the City. Completed Certificates of Insurance shall be filed with the City prior to the performance of services hereunder, provided, however, that Provider shall at any time upon request file duplicate copies of the policies of such insurance with the City. If, in the judgment of the City, prevailing conditions warrant the provision by Provider of additional liability insurance coverage or coverage which is different in kind, the City reserves the right to require the provision by Provider of an amount of coverage different from the amounts or kind previously required and shall afford written notice of such change in requirements thirty (30) days prior to the date on which the requirements shall take effect. Should the Provider fail or refuse to satisfy the requirement of changed coverage within thirty (30) days following the City's written notice, this Contract shall be considered terminated on the date that the required change in policy coverage would otherwise take effect. 16. NONDISCRIMINATION: Provider represents and warrants to the City that Provider does not and will not engage in discriminatory practices and that there shall be no discrimination in connection with Provider's performance under this Agreement on account of race, color, sex, religion, age, handicap, marital status or national origin. Provider further covenants that no CoM: PSA & Corp Reso Mercy Drug Testing 2009 8 otherwise qualified individual shall, solely by reason of his/her race, color, sex, religion, age, handicap, marital status or national origin, be excluded from participation in, be denied services, or be subject to discrimination under any provision of this Agreement. 17. MINORITY AND WOMEN BUSINESS AFFAIRS AND PROCUREMENT PROGRAM: The City has established a Minority and Women Business Affairs and Procurement Program (the "M/WBE Program") designed to increase the volume of City procurement and contracts with Blacks, Hispanic and Women -owned business. The MIWBE Program is found in Ordinance No. 10062, a copy of which has been delivered to, and receipt of which is hereby acknowledged by, Provider. Provider understands and agrees that the City shall have the right to terminate and cancel this Agreement, without notice or penalty to the City, and to eliminate Provider from consideration and participation in future City contracts if Provider, in the preparation and/or submission of the Proposal, submitted false of misleading information as to its status as Black, Hispanic and/or Women owned business and/or the quality and/or type of minority or women owned business participation. 18. ASSIGNMENT: This Agreement shall not be assigned by Provider, in whole or in part, without the prior written consent of the City's, which may be withheld or conditioned, in the City's sole discretion. 19. NOTICES: All notices or other communications required under this Agreement shall be in writing and shall be given by hand -delivery or by registered or certified U.S. Mail, return receipt requested, addressed to the other parry at the address indicated herein or to such other address as a parry may designate by notice given as herein provided. Notice shall be deemed given on the day on which personally delivered; or, if by mail, on the fifth day after being posted or the date of actual receipt, whichever is earlier. CoM: PSA & Corp Reso Mercy Drug Testing 2009 9 TO PROVIDER: Alfonso E. Ribero Director of Laboratory Services Mercy Medical Development d/b/a Mercy Outpatient Center 3649 South Miami Avenue Miami, FL 33133 20. MISCELLANEOUS PROVISIONS: TO THE CITY: Pedro G. Hernandez, P.E. City Manager City of Miami 3500 Pan American Drive Miami, Florida 33133 WITH A COPY TO: Hector Mirabile, Ph.D., Director City of Miami Department of Employee Relations 444 SW 2nd Avenue, Suite 739 Miami, Florida 33130 A. This Agreement shall be construed and enforced according to the laws of the State of Florida. Venue for any legal proceedings shall be Miami -Dade County, Florida. B. Title and paragraph headings are for convenient reference and are not a part of this Agreement. C. No waiver or breach of any provision of this Agreement shall constitute a waiver of any subsequent breach of the same or any other provision hereof, and no waiver shall be effective unless made in writing. D. Should any provision, paragraph, sentence, word or phrase contained in this Agreement be determined by a court of competent jurisdiction to be invalid, illegal or otherwise unenforceable under the laws of the State of Florida or the City of Miami, such provision, paragraph, sentence, word or phrase shall be deemed modified to the extent necessary in order to conform with such laws, or if not modifiable, then same shall be deemed severable, and in either CoM: PSA & Corp Reso Mercy Drug Testing 2009 10 event, the remaining terms and provisions of this Agreement shall remain unmodified and in full force and effect or limitation of its use. E. This Agreement constitutes the sole and entire agreement between the parties hereto. No modification or amendment hereto shall be valid unless in writing and executed by properly authorized representatives of the parties hereto. 21. SUCCESSORS AND ASSIGNS: This Agreement shall be binding upon the parties hereto, their heirs, executors, legal representatives, successors, or assigns. 22. INDEPENDENT CONTRACTOR: Provider has been procured and is being engaged to provide services to the City as an independent contractor, and not as an agent or employee of the City. Accordingly, Provider shall not attain, nor be entitled to, any rights or benefits under the Civil Service or Pension Ordinances of the City, nor any rights generally afforded classified or unclassified employees. Provider further understands that Florida Workers' Compensation benefits available to employees of the City are not available to Provider, and agrees to provide workers' compensation insurance for any employee or agent of Provider rendering services to the City under this Agreement. 23. CONTINGENCY CLAUSE: Funding for this Agreement is contingent on the availability of funds and continued authorization for program activities and the Agreement is subject to amendment or termination due to lack of funds, reduction of funds and/or change in regulations, upon thirty (30) days notice. 24. REAFIRMATION OF REPRESENTATIONS: Provider hereby reaffirms all of the representations contained in the Solicitation Documents. CoM: PSA & Corp Reso Mercy Drug Testing 2009 11 25. ENTIRE AGREEMENT: This instrument and its attachments constitute the sole and only agreement of the parties relating to the subject matter hereof and correctly set forth the rights, duties, and obligations of each to the other as of its date. Any prior agreements, promises, negotiations, or representations not expressly set forth in this Agreement are of no force or effect. 26. COUNTERPARTS: This Agreement may be executed in two or more counterparts, each of which shall constitute an original but all of which, when taken together, shall constitute one and the same agreement. IN WITNESS WHEREOF, the parties hereto have caused this instrument to be executed by their respective officials thereunto duly authorized, this the day and year above written. 64city " CITY OF NI AM, a municipal ATTEST: corporation Priscilla A. Thompson City Clerk By: Pedro G. Hernandez, P.E. City Manager CoM: PSA & Corp Reso Mercy Drug Testing 2009 12 "Provider" ATTEST: Mercy Medical Development, d/b/a Mercy Outpatient Center a Florida not-for-profit corporation By: Print Name: Sister Edith Gonzalez, SSJ Print Name: Laura Dominguez Title: Corporate Secretary Title: Vice -President, Business Development APPROVED AS TO LEGAL FORM APPROVED AS TO INSURANCE AND CORRECTNESS: REQUIREMENTS: Julie O. Bru Lee -Ann Brehm City Attorney Risk Management Director CoM: PSA & Corp Reso Mercy Drug Testing 2009 13 CORPORATE RESOLUTION WHEREAS, Mercy Medical Development d/b/a Mercy Outpatient Center desires to enter into an agreement with the City of Miami for the purpose of performing the work described in the contract to which this resolution is attached; and WHEREAS, the Board of Directors at a duly held corporate meeting has considered the matter in accordance with the By -Laws of the corporation; Now, THEREFORE, BE IT RESOLVED BY THE BOARD OF DIRECTORS that the is hereby authorized and instructed to enter into a contract, in the name and on behalf of this corporation, with the City of Miami upon the terms contained in the proposed contract to which this resolution is attached. DATED this day of , 2009. Chairperson of the Board of Directors Corporate Secretary (Corporate Seal) CoM: PSA & Corp Reso Mercy Drug Testing 2009 14 Attachment "A" SCOPE OF WORK DRUG SCREENING SERVICES PART I, PART II, PART IV, ANIS PART V Part I Services: Employment and Reasonable Suspicion Drug Screening Services A. Collection Facility B. Drug Testing Facility C. MRO Services Part II Services: Sworn Fire Drug Screening Services A. Collection Facility B. Drug Testing Facility C. MRO Services Part IV Services: Random Alcohol and Drug Screening Services for AFSCME,. Local `871 Employees A. Collection Facility B. Drug Testing Facility C. MRO Services Part V Services: Sworn Police Drug Screening Services A. Collection Facility B. Drug Testing Facility C. MRO Services Part I Services Employment and Reasonable Suspicion Drug Screening Services Scope of Work: A. Collection Facilitv 1. All collections must be performed in accordance with Agency for Health Cate Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 2. Provider's collection facility must. be located within a 5 mile radius of Cita of Miami ("City") limits. n lieu of a collection facility, a self contained mobile unit will serve as the collection facility. 3. Provider's collection facility must follow Agency for Health Care Administration (AIHCA) and/or .Substance Abuse and -Mental Health Services Administration (SAMHSA) guidelines. 4. Provider must be able to conduct the following services: collect specimen for urinalysis, blood alcohol level, and perform Evidential Breath Testing (EBT). 5. Provider must ensure and pay for next day delivery to testing facility. 6. Vehicle parking shall be provided at no cost to the City, employee, or applicant being tested. 7. Provider's collection facility must have a sufficient reception area. This does not apply to a self contained mobile unit. 8. Provider must be able to accommodate large groups of applicants during peak times of the year average of .50-100 applicants on any given day (i.e. 1 Summer Parks and Recreation' Program, and during Police Officer and Firefighter recruitments). 9. The City may.require an interview of Proposers and inspection of facilities and equipment prior to award of the Contract and request for a mock process on how Proposer will collect specimen to determine responsiveness and compliance with the City of Miami Protocol. 10. Provider must maintain all financial records customarily used in this type of operation in accordance with accepted accounting practice and standards. The City shall, through the City auditors, be permitted to examine and audit during ordinary business hours, the records of City accounts. 11. Provider must be able to perform collection services Monday — Friday,,between the hours of 8:00 a.m. — 5:00 p.m. In the event of an emergency, provider must be able to provide collection services after 5:00 p.m. and/or on the weekend/holiday. 12, On request, Provider must be able to collect specimens at a location other than the Provider's collection site. 13. The City will only pay invoices submitted by the facility for which a purchase order has been issued. 2 14. Collection services will be provided primarily for prospective employees and current employees. NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to comply with specified requirements and for detailed specifications. City of Miami Drug Screening Protocol is subject to change. B. Drug Testing Facility 1. All tests must be performed in accordance with Agency for Health Care Admuustratiop (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMIISA) guidelines. 2. All tests must be performed by an individual who has the qualifications outlined in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 3. Provider's testing facility must be currently certified by the Agency for Health Care Administration .(AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). State of Florida certificate must be for forensic toxicology. 4. Provider must be able to conduct the following tests: urinalysis (innmunoassay), gas chromatography -mass spectrometry (GCMS), and blood alcohol level, and provide results to the City in compliance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 5. The City may require interviews of Proposers and inspection of facilities and equipment prior to award of the Contract. 6. Provider must maintain all financial records customarily used in this type of operation in accordance with accepted accounting practice and standards. The City shall, 'through the City auditors, be permitted to examine and audit during ordina business hours, the records of City accounts. 7. Provider must be able to perform drug testing Monday - Friday, between the hours of 8:00 a.m. - 5:00 p.m. In the event of an emergency, provider must be able to provide testing after 5:00 p.m. and/or on the weelcend/holiday. 8. The City will only pay invoices submitted by the facility for whom a Purchase Order has been issued. 3 9. Provider must provide to the collection facility(ies) all necessary supplies (e,g., collection kits which, as applicable, shall contain chain of custody forms, mailing boxes or containers, specimen identification labels, laboratory address labels, urine specimen bottles, external .temperature strips,, tamper -proof plastic sealable bags and forensic tamper -proof tape to seal the specimen container(s), etc. in accordance with Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines, 10. Provider must be able to adhere to specified cut-off levels in accordance with Agency for Health Care Administration (ARCA) anal/or Substance Abse and Mental Health Services Administration (SAMHSA) guidelines. 11. Personnel involved in the administration of drug screens as required by the City of Miami must testify on behalf of the City in case or a court hearing, Civil Service hearing, or similar proceedings, relative to testing procedures. Qualified laboratory personnel must also be available to meet with City representatives to discuss testimony -related to the aforementioned proceedings. 12. Testing is primarily for prospective employees (employment drug testing)- and current employees (employment/promotional drug testing and/or reasonable suspicion testing)., NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to comply with specked requirements and for detailed specifications. City of Miami Drug Screening Protocol is subject to change. C. MRO Services 1, Medical Review Officer shall be certified as medical review officer in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 2. The MRO shall not be employed or contracted by the drug testing laboratory. The drug testing laboratory is permitted to assist in locating qualified medical review officers. The MRO may be employed by the collection facility, 3. The MRO shall evaluate the drug test result(s), which is reported out by the laboratory, in accordance with Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 4 4. The IMR0 shall report negative and positive results to the City in accordance with Agency for Health Care, Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. Part 11 Services Sworn Fire Drug Screening Services Scope of Work: A. Collection Facility 1. All collections must be performed in accordance with Agency for Health Care- Administration areAdministration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to. comply with specified requirements and for detailed specifications. City of Miami Drug .Screening Protocol is subject to change. 2. Provider's collection facility must be located _within a 5 mile radius of City of Miami("Citi limits, j lieu of a collection facility, a self contained mobile unit will serve as the collection facility. 3. Provider's collection facility must follow Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines, 4. Provider must be able to conduct the following services: collect specimen for urinalysis, blood alcohol level, and perform Evidential Breath Testing (EBT). 5. Provider must ensure and pay for neat day delivery to .testing facility, 6. Vehicle parking shall be provided at no cost to the City, employee, or applicant be,ing-testeciT - - -- 7. Provider's collection facility must have a sufficient reception area. This does, not apply to a self contained mobile unit. 8. The City may require an interview of Proposers and inspection of facilities and equipment prior to award of the Contract and request for a mock process on how Proposer will collect specimen to determine responsiveness and compliance with the City of Miami Protocol. 5 9. Provider must maintain all financial records customarily used in this type of operation in accordance with accepted accounting practice and standards, The City shall, through the City auditors, be permitted to examine and audit during ordinary business hours, the records of City accounts. 10. Provider must be able to perforin collection services Monday — Friday, between the hours of 8:00 a.m. — 5:00 p.m. In the event of an emergency, provider must be able to provide'collection services after 5:00 pan. and/or on the weekend/holiday. 11. On request, Provider must be able to collect specimens at a. location other than the Provider's collection site. 12. The City will only pay invoices submitted by the facility for which a purchase order has been .issued. 13. Collection services will be provided primarily for all sworn members of the Fire Department. NOTE: The City's Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to comply with specified requirements and for detailed specifications. B. Drug Testing Facility 1. All tests must be performed in accordance with Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 2. A11 tests must be performed by an individual who has the qualifications outlined in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 3. Provider's testing facility must be currently certified by the Agency for Health Care Administration (ARCA) - and/or Substance Abuse and Mental Health Services Administration (SAMHSA). State of Florida certificate must be for -ore oxi�cr -- 4. Provider must be able to conduct the following tests: urinalysis (immunoassay), gas chromatography -mass. spectrometry (GCMS), and blood alcohol level, and provide results to the City in compliance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. rol 5. The City may require interviews of Proposers and inspection of facilities and equipment prior to award of the Contract. 6. Provider must maintain all financial records customarily used in this type of operation in accordance with accepted accounting practice and standards. The City shall, through the City auditors, be permitted to examine and audit during ordinary business hours, the records of City accounts. 7. Provider must be able to perform drug testing Monday - Friday, between the hours of 8:00 a.m. - 5:00 p.m. In the event of an emergency, provider must be able to provide testing after 5:00 p.m. and/or on the weekend/holiday. 8. The City will only pay invoices submitted by the facility for whom a Purchase Order has been issued. 9. Provider must provide to the collection facility(ies) all necessary supplies (e.g., collection kits which, as applicable, shall contain chain of custody forms, mailing boxes or containers, specimen identification labels, laboratory address labels, urine specimen bottles, external temperature strips, tamper -proof plastic sealable bags and forensic tamper -proof tape to seal the specimen container(s), etc, in accordance with Agency for -Health Care Administration (_ARCA) and/or Substance -Abuse and Mental Health Services Administration (SAMHSA.) .guidelines. 10. Provider must be able to adhere -to specified cut-off levels in accordance with the City of Miami Drug Screening Protocol for Sworn Fire Personnel. 11. Personnel involved in the administration of drug screens as required by the City of Miami must testify on behalf of the City in case or a court hearing, Civil Service hearing, or similar proceedings, relative to testing procedures. Qualified laboratory personnel must also be available to meet with City representatives to discuss testimony related to the aforementioned proceedings. 12. Testing is primarily for all sworn members of the Fire Department (random testing and reasonable suspicion testing per the labor agreement). NOTE: City of Miami Drug Screening Protocol should be reviewed carefully o ensure ProVider,s a i ity to comply with specs ie requiremen s (specifically turn.!around time for reporting of positive test results) and for detailed specifications. City of Miami Drug Screening Protocol is subject to change. C. MRO Services 7 1. Medical Review Officer shall be certified as medical review officer in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 2. The MRO shall not be employed or contracted by the drug testing laboratory. The drug testing laboratory is permitted to assist in locating qualified medical review officers. The MRO may be employed by the collection facility. 3. The MRO shall evaluate' the drug test iesult(s), which is reported out by the laboratory, in accordance with Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 4. The MRO shall report negative and positive results to the City in accordance with City of Miami Drug Screening Protocol for Sworn Fire Personnel, NOT IN ACCORDANCE WITH SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (SAMHSA) GUIDELINES. The MRO must be able to adhere to specified cut-off levels in accordance with the City of Miami Drug Screening Protocol for Sworn Fire Personnel. NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure. Provider's ability to comply with specified requirements (specifically turn.,around timeifor reporting of positive -test results) and for detailed specifications. City of Miami Drug Screening Protocol is subject to change. Part IV Services Random Alcohol and Drug Screening Services for AFSCME, Local 871 Employees Scone of Work: A. Collection Facility l. All collections must be perf-ormed in accordance vn h Agency or - ea are Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to comply with specified requirements and for detailed specifications. City of Miami Drug Screening Protocol is subject to change. 2. Provider's collection facility must be located within a 5 mile radius of Citv of Miami ("City") limits. In lieu of a collection facility, a self contained mobile unit will serve as the collection facility, 3. Provider's collection facility must follow Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 4. Provider must be able to conduct the .following services: collect specimen for urinalysis, blood alcohol level, and perform Evidential Breath Testing (EBT). 5. Provider must ensure and pay for next day delivery to testing facility. b. Vehicle parking shall be provided at no cost to the City, employee, or applicant being tested. 7. Provider's collection facility must have a sufficient reception area. This does not apply to a self contained mobile unit. 8. The City may require an interview of Proposers and inspection of facilities and equipment prior to award of the "Contract and request for a mock process on how Proposer will collect specimen to determine responsiveness and compliance with the City ofNfiami Protocol. 9. Provider must maintain all financial records customarily used it this type of operation in accordance with accepted accounting practice and standards. The City shall, through the City auditors, be permitted to examine and audit during ordinary business hours, the records of City accounts. 10, Provider must be able to perform collection services Monday — Friday, between the hours of 8:00 a.m. - 5:00 p.m. In the event of an emergency, provider must be able to provide collection services after 5:00 p.m. and/or on the weekend/holiday. 11. Oil request, Provider must be able to collect specimens at a location other than the Provider's collection site. 12. The City will only pay invoices submitted y the facility for which a purchase order has been issued. 13. Collection services will be provided primarily for all sworn members of the Fire Department. 0 NOTE: The City's, Drug Screening Protocol should be reviewed carefully to ensure Provider's' ability to comply with specified requirements and for detailed specifications. B. DrugTesting Facility 1. All tests must be performed 'in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) -guidelines, 2. All tests must be performed by an individual who has the qualifications outlined in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 3. Provider's testing facility must be currently certified by the Agency for Health Care Administration (AHCA). and/or Substance Abuse and Mental Health Services Administration (SAMHSA). State of Florida certificate must be for forensic toxicology. 4. Provider must -be able to conduct the following tests: urinalysis (immunoassay), gas chromatography -mass spectrometry (GCMS), and blood alcohol level, and provide results to the City in compliance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) .guidelines. 5. The City may require interviews of Proposers and inspection of facilities and equipment prior to award of the Contract. 6. Provider must maintain all financial records customarily used in this type of operation in accordance with accepted accounting practice and standards. The City shall, through the City auditors, be permitted to examine and audit during ordinary business hours; the records of City accounts. 7. Provider must be able to perform drug testing Monday - Friday, between the hours of 8:00 a.m. 5:00 p.m. In the event of an emergency, provider must be able to provide. testing after 5:00 .p.m. and/or on the weekend/holiday. 8. The City will only pay invoices submitted by the facility for whom a Purchase Order has beendssued. 9. Provider must provide to the collection facility(ies) all necessary supplies (e.g., -collection kits which, as .applicable, shall contain chain of custody forms, mailing boxes or containers, specimen identification labels, laboratory address labels, urine specimen bottles, external. temperature strips, tamper -proof plastic sealable ITE bags and forensic tamper-proof tape to seal the specimen confainer(s), etc, in accordance with' Agency for `Health :Care Administration. (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 10. Provider.must be able to adhere to specified cut-off levels in accordance with the City of Miami Drug Screening Protocol for AFSCME, Local 871 Employees 11. Personnel involved in the administration of drag screens as required by the City of Miami must testify, on behalf of the City in case or a court hearing, Civil Service hearing, or similar proceedings, relative to testing procedures. Qualified laboratory personnel must also be available to meet with City representatives to discuss testimony related to the aforementioned proceedings. 12. Testing is primarily for all sworn members of the Fire Department (random testing and reasonable suspicion testing per the labor agreement), NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to comply with specified requirements. The City of Miami Drug Screening Protocol is subject to change. C. MRO Services 1. Medical Review Officer shall be certified as medical review officer in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 2. The MRO shall not be employed or contracted by the drug testing laboratory. The drug testing laboratory is permitted to assist in locating qualified medical review officers. The MRO may be employed by the collection facility. The MRO shall evaluate the drug test result(s), which is reported out by the laboratory, in accordance with Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMITSA) guidelines. 4. The MRO shall 'report negative and positive results to the City in accordance with gency for Health Uare Admirustration and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. Part V Services Sworn Police Officer Drug Screening Services A. Collection Facility 1. All collections must be performed in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to comply with specified requirements acid for detailed specifications. City of Miami Drug Screening Protocol is subject to change.. 2. Provider must be able to provide a self contained rnobile unit 3. Provider's collection facility must follow Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 4. Provider must be able to conduct the following services: collect specimen for urinalysis, blood alcohol level, and perform Evidential Breath Testing (EBT). 5. Provider must ensure and:pay for next day delivery to testing facility. b. Vehicle parking shall be provided at no cost to the City, employee, or applicant being tested. 7. Provider's collection facility must have a sufficient reception area. This does not apply to a self contained mobile unit. 8. The City may require an interview of Proposers and inspection of facilities and equipment prior to award of the Contract and request for a mock process on how Proposer will collect specimen to determine responsiveness and compliance with the City of Miami Protocol. 9. .Provider must maintain all financial records customarily used in this type of operation in accordance with accepted accounting practice and standards. The City shall, through the City auditors, be permitted to examine and audit during 10. Provider must be able to perform collection services Monday — Friday, between the hours of 7:00 a.m. ; 5:00 .p.rn,, and 9:00 p.m. — 12:00 a.m. In the event of an emergency, provider must be able to provide collection services before 7:00 a.m. and/or after 5:00 p.m. and/or on the weekend. 12 11. On request, Provider must be able to collect specimens at a location other than the Provider's collection site. 12. The City will only pay invoices submitted by the facility for which a purchase order has been issued. 13. Collection services will be provided primarily for all sworn members of the Fire Department. NOTE: The City's Drug Screening Protocol.should be reviewed carefully to ensure Provider's ability to comply with specified requirements and for detailed specifications. B. Testing Facility 1. All tests must be performed in accordance with Agency for Health Care Administration (ARCA) and/or. Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 2. All tests must be performed by an individual who has the qualifications outlined in accordance with Agency for Health Care Administration (ARCA) .and/or Substance Abuse and Mental. Health Services Administration (SAMHSA) guidelines.. 3. Provider's testing facility must -.be currently certified by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). State of Florida certificate must be for forensic toxicology. 4. Provider must be able to conduct the following tests: urinalysis (immunoassay), gas chromatography -mass spectrometry (GCMS), and blood alcohol level, and provide results to the City in compliance with Agency for Health Care Administration (ARCA) acid/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 5. The City may require interviews of Proposers and inspection of facilities and equipment prior to award of ffie Contract. 6. Provider must maintain all financial records customarily used in this type of operation in accordance with accepted accounting practice and standards. The City shall, through the City auditors, be permitted to examine and audit during ordinary business hours, the records of City accounts. 13 7. Provider must be able to perform drug testing Monday -Friday, between the hours of 8:00 a.ni. - 5:00 p.m. In the event of an emergency, provider must be able to provide testing after 5:00 p.m. and/or on.the weekend/holiday. 8. The City will only pay invoices submitted by the facility for whom a Purchase Order has been issued. 9. Provider must provide to the collection facility(ies) all necessary supplies (e.g., collection kits which, as applicable, .shall contain chain of custody forms, mailing boxes or containers; specimen identification labels, laboratory address labels, urine specimen bottles, external temperature strips, tamper -proof plastic sealable bags and forensic tamper -proof tape to seal the specimen container(s), etc. in accordance with Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAM7ISA) guidelines. 10. Provider must be able to adhere to specified cut-off levels in accordance with the City of Miami Drug Screening Protocol for Sworn Police Officer Personnel, 11. Personnel involved in the administration of drug screens as required by the City of Miami must testify on behalf of the City in case or a court hearing, Civil Service hearing, or similar proceedings, relative to testing procedures. Qualified laboratory personnel must also be available to meet with City representatives to discuss testimony related to the aforementioned proceedings. 12. Testing is primarily for all sworn members of the Fire Department (random testing and reasonable suspicion testing pet the labor agreement). NOTE: City of Miami Drug Screening Protocol should be reviewed carefully to ensure Provider's ability to comply with specified requirements and_, for detailed specifications. City of Miami Drug Screening Protocol is subject to change. C. MRO Services I. Medical Review Officer shall be certified as medical review officer in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mentalea flr�ervrces Administration guidelines. 2. The MRO shall not be employed or contracted by the drug testing laboratory. The drug testing laboratory is permitted to assist in locating qualified medical review officers. The MRO may be employed by the collection facility. 3. The MRO shall evaluate the drug test result(s), which is reported out by the laboratory, in accordance with Agency for Health Care Administration (AHCA) 14 and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 4. The MRO shall report negative and positive results to the City in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. 15 CITY OF MIAMI DRUG SCREENING PROTOCOL Part I Services: • Employment Drug Screening Services for all Prospective City of Miami Employees • Reasonable Suspicion Drug and Alcohol Screening Services for Current Employees including AFSCME Local 1907 Employees (General Employees), Man ageiial/Confi.dential Employees and Unclassified/Executive Employees (Excluding Sworn Police, Fire and AFSCME, Local 871 --Solid Waste Employees) Pursuant to City Commission policy and the various labor agreements, the City of Miami performs drug screens on current and prospective employees. The City of Miami drug screening program shall test for blood alcohol (if requested) and the following controlled substances:. -Initial Test Level (ng/ml) GC/MS Level (nQ/ml) Amphetamines 1000 500 Cannabinoids 50 15 Cocaine (benzoylecgonine) 300 150 Phencyclidine 25 25 Methaqualone i 300 150 Opiates 2000 2000 Barbiturates 300 150 Benzodiazepines 300 150 Methadone 300 150 Propoxyphene 300 150 Methylene.dioxymethamphetamine NOTE: These drug testing panels and cut-off concentrations are subject to revision with changes in convention or technology. The following guidelines have been established in conjunction with standards developed by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) and existing City of Miami departmental policies and procedures, as well as requirements set forth in the existing collective bargaining agreements: SPECIMEN COLLECTION SERVICES 1. Chain of Custody A chain of study of custody standardized form shall be properly executed by authorized collection site personnel upon receipt of specimen as determined by the Agency for Health Care Administration (AHCA) and/or Substance .Abuse and Mental Health Services Administration (SAMHSA). Handling and transportation of urine and/or blood specimens from one authorized individual or place to another shall always be accomplished through chain of custody procedures as determined by AHCA and/or SAMHSA. Every effort shall be made to minimize the number of persons handling specimens. 2. Integrity and Identity of Specimen Collection site personnel shall tape precautions to ensure that a urine specimen not be adulterated or diluted during. the collection procedure and that information on the urine bottle and chain of custody form can identify the individual from whom the specimen was collected as per Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines.. The necessary precautions shall be taken to ensure that unadulterated specimens are obtained and correctly identified as determined by AHCA and/or SAMHSA, as well as in addition to City of Miami established policies and procedures, A. When an individual arrives at the collection site, the collection site person shall require the individual to present photo identification. If the individual's identity cannot be- established,. thei collection site person .shall not proceed with the collection until identity has been established. The City of Miami, Depaztment of Employee Relations must be notified immediately at (305) 416-2100 of those cases in which identity cannot be established. In those _ cases involving reasonable suspicion, employee must be escorted y a supervisor, employee must present poo i enti rca ion an specimen collection must be taken "under direct observation". B. The individual shall be instructed to wash and dry his or her hands prior to urination, if such facilities are available. The collection area shall meet the requirements determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). C. The individual shall remain in the presence of the collection site person and shall not have access to a water fountain, faucet, soap dispenser, cleaning agent or any other material which could be used to adulterate the specimen. Only one (1) individual shall be allowed inside the collection area (restroom) at any given time. The individual shall not be allowed to bring anything, including any smoking materials, into the collection area. The individual shall remove all unnecessary outer garments. All bags, packs, purses, etc., shall be left outside of the collection area (restroom)secured.in a locked unit. The individual may retain his or her wallet. D. The individual shall be given the necessary container(s) as determined by the Agency for Health Care Administration and/or Substance Abuse and Mental Health Services Administration (SAMHSA) for specimen collection. . E. Prior to allowing the individual to enter the collection area, the collection site person shall examine the area (restroom) as determined by the Agency for Health Care Services Administration (ARCA) and/or Substance Abuse and Mental Health. Services Administration (SAMHSA) and shall verify that a water soluble colored dye is in the toilet if required. R Instructions provided by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) .shall be provided by the collection site person to the'individual as to not to flush the toilet until the specimen has.been given -to the collection site person, and it is deemed to be an acceptable sample. If applicable, the employee shall be told that if the sound of running water is heard coming from within the restroom, by the collection site person, the individual shall be .instructed to exit the restroom and informed .that the sample, if any, does not meet the City of Miami guidelines. The sample shall be considered as adulterated, and will be taken into custody by the collection site person and retained for analysis. G. The individual shall enter the collection area (restroom), close the door for privacy and void into the container, The collection site person shall remain near the restroom facility (collection area), within audible range of the individual. H. The collection site person shall document any unusual behavior or appearance of. the individual. Upon receiving the specimen from the individual, the collection site person shall confirm that the applicant/employee has provided the required amount of urine -as determined by Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). If the individual fails for any reason, to provide the required amount of urine, the procedure must be initiated from the beginning and the applicant/employee must be instructed not to leave the premises (NOTE; specimen collection must take place on the same day or the applicant will be "DISQUALIFIED" from the hiring process). After the specimen has been provided and submitted to the collection site person, the individual shall be allowed to wash his or her hands. K. Immediately after the specimen is collected, the collection site person, in the presence of the individual, shall inspect the specimen to determine the color and look for any signs of contaminants as required by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). L. Immediately upon receiving the specimen, the collection site person shall check the temperature sensitive label on the specimen cup to determine if it is at an acceptable temperature as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). If the specimen's temperature is not within the acceptable range,11he proper testing reporting procedures should be followed in accordance with AHCA and/or SAMHSA.guidelines. M. Guidelines established by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services (SAMHSA) should be followed if there is any suspicion. of a specimen being adulterated. N. The donor should provide the amount of specimen required by the Agency for Health Care Administrations (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). 0. The collection site person shall place securely on the bottles the required identification label which as determined by the Agency for Health Care Administration ARCA an or Substance Abuse and Mental Health Services Administration (SAMHSA). .P. If required, the -;individual' shall initial ' the evidence tape/identification label portion of the specimen bottles for the purpose of certifying that they are the specimens collected from him or her. Q. The collection site person must place the specimens and chain of custody form in secure location as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration ,(SAMHSA). DRUG TESTING (LABORATORY FACILITY) QUALIFICATIONS/SERVICES Security and Chain of Custody The drug testing laboratory shall be secure at all times. Sufficient security measures to control access to the premises and to ensure that no unauthorized personnel handle specimens or gain access to the laboratory processes or to areas where records are .stored must be in place. Access to these secured areas shall be limited to specifically authorized individuals whose authorization is documented. Laboratories shall use chain of custody procedures to maintain control and accountability of specimens from receipt through completion of testing, reporting of results, during storage, and continuing until final disposition of specimens. The date and purpose shall be documented on an appropriate chain .of custody form each time a specimen is handled or transferred, and every individual in the chain shall be identified. Accordingly, authorized technicians shall be responsible for each urine specimen or aliquot in their possession and shall sign and complete chain of custody forms for those specimens or aliquots as they are received. A. The laboratory must be licensed and approved by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) ' using criteria established by the United .States Department of Health and Human Services as general guidelines for the City of Miami's drug testing program. B. The provider must have a qualified individual as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) to review the standards, control specimens and quality control data together. with the` screening and confirmation test results; a licensed technologist supervisor and licensed technicians (all licensed by the State of Florida). A phlebotomist must.be available to draw blood specimens; and a Breath AIcohol Technician (BAT) trained to proficiency in the federal alcohol testing procedures must also be available. C. All tests shall be conducted in a licensed facility operated by the provider or at such facility subsequently agreed to by the City and the provider. Laboratory facility must be currently licensed and approved by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). Laboratory must have the capability of performing drug screenings and GCMS confirmations at the same facility. 5 The provider's premises and equipment must have passed all inspections by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). D. The provider's facility must have a quality assurance program which encompasses all aspects of the testing process: specimen acquisition, chain of custody security and reporting :results, in addition to the screening and confirmation of analytical procedures: Quality control procedures will be designed, implemented and reviewed to monitor the conduct of each step of the process. The provider's facility must meet or exceed standards established by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). E. The provider must have experience in handling toxicology specimens (both urine and blood) and provide a well documented chain of custody for all tests as determined' by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA). F. The provider must have a procedures manual as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA) to ensure chain of custody. G. The provider must follow proper quality control procedures including, but not limited to the use of internal quality controls including the use of samples of known concentrations which are used to- check the performance and calibration of testing equipment, and periodic use of blind samples for overall accuracy; an internal review and certification process for drug test results, conducted by a person qualified to perform that function in the testing laboratory; security measures implemented by the testing laboratory to preclude adulteration of specimens and drug test results; and any other required steps to ensure reliable and accurate drug test results. G. The provider shall maintain' documentation bf all aspects of the testing process as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). H. The provider shall esigna e a program manager who wi- e res ponsre—fo`r program coordination and to provide a single point interface between the purchaser and the provider on all matters concerning the contract. The provider shall provide a 'written test result report to the City of Miami, Department of Employee Relations in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration guidelines. MEDICAL REVIEW OFFICER (MRO) QUALIFICATIONS/SERVICES A. The Medical Review Officer (MRO) shall be certified as a Medical Review Officer in accordance with the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. B. The MRO shall evaluate the drug test result(s), which is reported out by the laboratory, in .accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse .and Mental Health Services Administration (SAMHSA) guidelines. C. If the MRO. is unsuccessful in contacting an applicant/employee regarding drug or alcohol testing results, he/she is to contact the City of Miami, Department of Employee Relations at (305) 416-2100 for assistance in contacting the individual and expediting the reporting of results. D. The MRO shall notify the City of Miami, Department of Employee Relations at (305) 416-2100 immediately upon confirmation of a positive drug test result. Please note that this Drug Screening Protocol is subject to revision and change. Part II Services: CITY OF MIAMI DRUG SCREENING PROTOCOL Sworn Fire Drug and Alcohol Screening Services (Random and Reasonable Suspicion Testing) Pursuant to Article 31 of the IAFF Labor Agreement, in an effort to identify and eliminate on or off-duty controlled substance/alcohol abuse, the City of Miami administers urinalysis/blood tests for alcohol testing (if requested) on sworn Fire personnel. - . The following cut-off concentrations shall be applicable for determining whether specimens are negative or positive for the following drugs or classes of drugs for the initial and confirmatory test procedures. A positive result shall be a concentration in excess of those listed below. For those "designer drugs" that -are listed below without cut-off levels, the parties agree to test in accordance with levels specified by the Department of Human Services Federal Register, Part III, if and when it ever becomes available: Initial Test Level (n6/ml) Cannabinoid (Marijuana) Metabolites 50 Cocaine Metabolites 300 Opiate Metabolites 2,000 Phencyclidine 25 Amphetamines 1,000 Methaqualone 300 Methadone 300 Propoxyphene 300 Tricyclic Antidepressants 300 Designer Dnigs:- Ketamine TBD Nlethylenedioxymethamphetamine TBD (Ecstasy) GC81S Test Level / nI Cannabinoid (Marijuana) Metabolites ' 15 Cocaine Metabolites 150 Opiates Morphine 2,000 Codeine 2,000 6-Acetylmorphine 10 Phencyclidine 25 Amphetamines Amphetamine 500 Methamphetamine 500 Meihaqualone 300 Designer Drugs: Ketamine TBD Methylenedioxymethamphetamine TBD (Ecstasy) Initial test results for alcohol will be considered positive when the individual's blood alcohol content is 0.04 grams per dl or greater using whole blood. Alcohol related specimens identified as positive by the initial test shall be confirmed as positive by Gas Chromatography Volatiles Head Space Method or more reliable testing for whole blood at 0.04 grams per dl or greater. NOTE: These drug testing panels and cut-off concentrations are subject to revision with changes in convention or technology. The following guidelines have been established in conjunction with standards developed by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health. Services Administration (SAMHSA) and existing City of Miami departmental policies and procedures, as well as requirements set forth in the existing collective bargaining agreement: SPECIMEN COLLECTION SERVICES 1. Chain of Custody A chain of study of custody standardized form shall be properly executed by authorized collection site personnel upon receipt of specimen as determined by the Agency for Health Care Administration (AHCA). and/or Substance Abuse and Mental Health Services Administration (SAMHSA). Handling and transportation of urine and/or blood specimens from one authorized . individual or place to another shall always be accomplished,through':chain-of custody procedures as determined by AHCA and/or SAMHSA. Every effort shall be made to minimize the number of persons handling specimens. 2. Integrity and Identity of Specimen Collection site personnel shall take precautions to ensure that a urine specimen not be adulterated or diluted during the collection procedure and that information on the urine bottle and chain of custody form can identify the individual from whom the specimen was collected as per Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMIISA) guidelines. The necessary precautions shall be taken to ensure that unadulterated specimens are obtained and correctly identified as determined by AHCA and/or SAMHSA, as well as in addition to City of Miami established policies and procedures. A. When an individual arrives at the collection site, the collection site person shall require the individual to present photo identification. If the individual's identity cannot be established, the collection site person shall not proceed with the collection until identity has been established. The City of Miami, Department of Fire -Rescue must be notified immediately at (305) 416-5450 of those cases in which identity cannot be established. In those cases involving reasonable suspicion, employee must be escorted by a supervisor, employee must .present photo identification and specimen collection must be taken "under direct observation". B. Employees shall give either a blood sample, for suspected alcohol use or a urine sample for suspected substance abuse as determined by the City. The individual shall be instructed to wash and dry his or her hands prior to urination, if such facilities are available. The collection area shall meet the requirements determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). 10 C. The individual shall remain in the presence of the collection site person and shall not have access to a water fountain, faucet, soap dispenser, cleaning agent or any other material which could be used to adulterate the specimen. Only one (1) individual shall be allowed inside the collection area (restroom) at any given time. The individual shall not be allowed to bring anything, including any smoking materials, into the collection area. The individual shall remove all unnecessary outer garments. All bags, packs, purses, etc., .shall be left outside of the collection area (restroom) secured in a locked unit. The individual may retain his or her wallet. D. The individual shall be given the necessary container(s) as determined by the Agency for Health Care Administration and/or Substance Abuse and Mental Health Services Administration (SAMHSA) for specimen collection. E. Prior to allowing the individual to enter the collection area, the collection site person shall examine the area (restroom) as determined by the Agency for Health Care Services Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) and shall verify that a water soluble colored dye is in the toilet if required. F. Instructions provided by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) shall be provided by the collection site person to the individual as to not to flush the toilet until the specimen has been given to the collection site person, and it is deemed to be an acceptable sample. If applicable, the employee shall be told that if the sound of nuuiing water is heard coming from within the restroom, by the collection site person, the .individual shall be instructed to exit the restroom and informed that the sample, if any, does not meet the City of Miami guidelines. The sample shall be considered as adulterated, and will be taken into custody by the collection site person and retained for analysis. G. The individual shall enter the collection area (restroom), close the door for privacy and void into the container. The collection site person shall remain near the restroom facility (collection area), within audible range of the individual. H. The collection site person shall document any unusual behavior or appearance of the. individual. 11 Upon receiving the specimen from the individual, the collection site person shall confirm that the applicant/employee has provided the required amount of urine as determined by Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). If the individual fails for any reason, to provide the required amount of urine, the procedure must be initiated from the beginning and the employee must be instructed not to leave the premises. After the specimen has been provided and submitted to the collection site person; the individual shall be allowed to wash his or her hands. K. Immediately after the specimen is collected, the collection site person, in the presence of the individual, shall inspect the specimen to determine the color and look for any signs of contaminants as required by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). L. Immediately upon receiving the specimen, the collection site person shall check the temperature sensitive label on the specimen cup to determine if it is at an acceptable temperature . as determined by the Agency for Health Care Administration (AHCA) and/or' Substance Abuse and Mental Health Services Administration (SAMHSA). If the specimen's temperature is not within the acceptable range, the proper testing reporting procedures should be followed in accordance with ARCA and/or SAMHSA guidelines, and appropriate personnel from the Department of Fire -Rescue shall be notified immediately. M. Guidelines established by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services (SAMHSA) should be followed if there is any suspicion of a specimen being adulterated. N. The donor should provide the amount of specimen required by the Agency for Health Care Administration (AHCA) and/or .Substance Abuse and Mental Health Services Administration (SAMHSA). O. The collection site person shall place securely on the bottles the required identification label which as determined by the Agency for Health Care Administration HCA) Oo nrmu Abusa and Meintal Health i e Administration (SAMHSA). P. If required, the individual shall initial the evidence tape/identification label portion of the specimen bottles for the purpose of certifying that they are the specimens collected from him or her. 12 Q. The collection site person must place the specimens and chain of custody form in secure location as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). DRUG TESTING (LABORATORY FACILITY) QUALIFICATIONS/SERVICES Security and Chain of Custody The drug testing laboratory shall be secure at all times. Sufficient security measures to control access to the premises and to ensure that no unauthorized personnel handle specimens or gain access to the laboratory processes or to areas where records are stored must be in place. Access to these secured areas shall be limited to specifically authorized individuals whose authorization is documented. Laboratories shall use chain of custody procedures to maintain control and accountability of specimens from receipt through completion of testing, reporting of results, during storage, and continuing until final disposition of specimens. The date and purpose shall be documented on an appropriate chain of custody form each time a specimen is handled or transferred, and every individual in the chain shall be identified. Accordingly, authorized technicians shall be- responsible eresponsible for each urine specimen or aliquot in their possession and shall sign and complete -chain of custody forms for those specimens or aliquots as they are received. A. The laboratory must be licensed and approved by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) using criteria established by the United States Department of Health and Human Services as general guidelines for the City of Miami's drug testing program. B. The provider must have a qualified individual as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) to review the standards, control specimens and quality control data together with the screening and confirmation test results; a licensed technologist supervisor and licensed technicians (all licensed by the State of Florida): A phlebotomist must be available to draw blood specimens; and a Breath Alcohol Technician :(BAT) trained to proficiency in the federal alcohol testing procedures must also be available. C. All tests shall be conducted in a licensed .facility operated by the provider or at such facility subsequently agreed to by the. City and the provider. Laboratory facility must be currently licensed and approved by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). Laboratory must have the capability of performing drug screenings and.GCMS confirmations. at the same facility. 13 D. The provider's premises and equipment must have passed all inspections by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA), E. The provider's facility must have a quality assurance program which encompasses all aspects of the testing process: specimen acquisition, chain of custody security and reporting results, in addition to the screening and confirmation of analytical procedures. Quality control procedures will be designed, implemented and reviewed to monitor the conduct of each step of the process. The provider's facility must meet or exceed standards established by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). F. The provider must have experience in handling toxicology specimens (both urine and blood) and provide a well documented chain of custody for all tests as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA). G. The provider must have a procedures manual as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA) to ensure chain of custody. H. The provider must follow proper quality control procedures including, but not limited to the use of internal quality controls including the use of samples of known concentrations which are used to check the performance and calibration of testing equipment, and periodic use of blind samples for overall accuracy; an 'internal review and certification process for drug test results, conducted by a person qualified to perform that function in the testing laboratory; security measures dinplemented by the: testing- laboratory to preclude adulteration of specimens and drug test results; and any other required steps to ensure reliable and accurate drug test results. I. The provider shall maintain, documentation of all aspects of the testing process as determined by the Agency for Health Care Administration: (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). J. The provider shall esignate a program manager who will e responsible for program coordination and .to provide a single point interface between the purchaser and the provider on all matters concerning the contract. K. The provider shall provide a written test result report to the City of Miami, Department of Fire -Rescue in ' accordance with the Agency for Health Care Administration (ARCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA). NOTE: PER SECTION 31.3 OF THE IAFF 14 LABOR AGREEMENT, EMPLOYEES SHALL BE NOTIFIED OF A POSITIVE RESULT WITHIN TWENTY-FOUR (24) HOURS FROM RECEIPT OF THE LABORATORY REPORTS, BUT IN NO CASE SHALL THIS NOTICE OCCUR MORE THAN NINETY -SIS' HOURS (96) HOURS AFTER THE TIME THE SAMPLE WAS GIVEN. MEDICAL REVIEW OFFICER (MRO) QUALIFICATIONS/SERVICES A. The Medical Review Officer (MRO) shall be certified as a Medical Review Officer in accordance with the Agency for Health Care Administration (ARCA) and/or Substance .Abuse and Mental Health Services Administration (SAMHSA) guidelines. B. The MRO shall evaluate the drug test result(s), which is reported out by the laboratory, in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. C. If the MR0 is unsuccessful .in contacting an applicant/employee regarding drug or alcohol testing results, he/she is to contact the City of Miami, Department of Fire - Rescue of (305) 416-5450 for'assistance in' contacting the employee and expediting the reporting of results. D. The MRO shall notify the City of Miami, Department of Fire -Rescue immediately upon confirmation of a positive drug test result. NOTE: PER SECTION 31.3 OF THE IAFF LABOR AGREEMENT, EMPLOYEES SHALL BE NOTIFIED OF A POSITIVE RESULT WITHIN TWENTY-FOUR (24) HOURS FROM .RECEIPT OF THE LABORATORY REPORTS, BUT IN NO CASE SHALL THIS NOTICE OCCUR MORE THAN NINETY-SIX HOURS (96) HOURS AFTER THE TIME THE SAMPLE WAS GIVEN. Please note that this Drug Screening Protocol is subject to revision and change. 15 CITY OF MIAMI DRUG SCREENING PROTOCOL Part IV Services: Random and Reasonable Suspicion Drug and Alcohol Screening Senices for AFSCIVIE, Local 871 Employees (Pursu?nt to AFSCME, AFL-CIO, Local 871 Labor Agreement — Solid "Waste Employees) Pursuant to Article 37 of the Florida Public Employees Council 79, A:FSCME, AFL-CIO, Local 871 Labor Agreement, the. City of Miami performs random drug and alcohol screening based on a pool of all bargaining unit employees. Initial Test Level (ng/ml) Cannabinoid (Marijuana) Metabolites 50 Cocaine Metabolites 300 Opiate Metabolites Morphine 2000 Codeine ! 2000 6-Acetylmorphine (Test when the morphine concentration is greater than or equal. to 2000 ng/ml) Phencyclidine 25 Barbiturates 300 Benzodiazepine 300 Amphetamines Amphetamine 1000 Methamphetamine 1000 Methaqualone 750 Methylenedioxymethamphethamine _ (Ecstasy) Methylenedioxyamphetamine (MDA/Ice) 500 Flunitrazepam(Rohnyol) - -- � - (Roofies) 300 22 For Designer Drugs: Unless specified with cut-off concentration levels, will be determined by the Agency for Health Care Administration (ARCA) if standards exist, or industry standards if no existing ARCA standards. Per Article 37, Section 37.22 of the AFSCME, Local 871 Labor Agreement, "All specimens identified as positive by the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques. GC/MS conf"rrmation.procedures at the following cut- off concentration shall be used for the following drug:" GC/MS Test Level (ng/ml) Cannabinoid (Marijuana) Metabolites 20 Per Article 37, Section 37.23 of the AFSCME, Local 871 Labor Agreement, "For all other drugs listed below, the confirmatory test -shall dete4et the confirmed presence of the substance. The laboratory must be prepared to provide evidence from its quality control program to prove its capability of detecting such substances." GC/MS Test Level (ngjml) Cocaine Metabolites 150 Opiate Metabolites Morphine 2000 Codeine 2000 5-Acetylmorphine. (Test •when the morphine concentration is greater than or equal to 2000 ng/ml) 10 Phencyclidine 25 Barbiturates 250 Benzodiazepine 250 Amphetamines Amphetamine 500 Methamphetamine ' 500 Methaqualone 150 Methylenedioxymethainphetharnine (MDMA) (Ecstasy) 500 e iy ene ioxyarnp e amine — — (MDA/Ice) 500 Flunitrazepam(Rolinyol) (Roofies) 300 23 NOTE: These drug testing panels and concentrations are subject to revision with changes in convention or technology. The laboratory must be able to document its performance at the cut-off level by the use of quality control, both open and blind. The following guidelines have been established in conjunction with standards developed by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) and existing City of Miami departmental policies and procedures, as well as requirements set forth in the existing collective bargaining agreement: SPECIMEN COLLECTION SERVICES Chain of Custody A chain of study of custody standardized form shall be properly executed by authorized collection site personnel upon receipt of specimen as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). Handling and transportation of urine and/or blood .specimens from one authorized individual or place to another shall always be accomplished through chain of custody procedures as determined by ARCA and/or SAMHSA. Every effort shall be made to minimize the number of persons handling specimens. 2, Integrity and Identity of Specimen Collection site personnel shall take precautions to ensure that a urine specimen not be adulterated or diluted during the collection procedure and that information ori the urine bottle and chain of custody form can identify the individual from whom the specimen was collected as per Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. The necessary precautions shall be talcen to ensure that unadulterated specimens are obtained and correctly .identified as determined by AHCA and/or SAMHSA, as well as in addition to City of Miami established policies and procedures. A. When an individual arrives at the. collection site, the collection site person shall require the individual to present photo identification. If the individual's identity cannot be established, the collection site person shall not proceed with the collection until identity has been established, The City'of Miami, Department of Employee must be notified immediately at (305) 416-2100 of those cases in which identity cannot be established. In those cases involving reasonable suspicion, employee must be 24 escorted by a supervisor, employee must present photo identification and specimen collection Must be taken "under direct observation". B, Employees shall give an evidential breath test (EBT) solely for testing alcohol content, and urine specimen for drug screening. The individual shall be instructed to wash and dry his or her hands prior to urination, if such facilities are available. The collection area shall meet the requirements determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health. Services Administration (SAMHSA). C. The individual shall remain in the presence of the collection site person and shall not have access to a water fountain, faucet, soap dispenser, cleaning agent or any other material which could be used to adulterate the specimen. Only one (1) individual shall be allowed inside the collection area (restroom) at any given time. The individual shall not be allowed to bring anything, including any smoking materials, into the collection area. The individual shall remove all unnecessary outer garments. All bags, packs, :purses, -etc., shall be left outside of the collection area (restroom) secured in.a locked unit. The individual may retain his or her wallet. D. ` The individual shall be given the necessary container(s) as determined by the Agency for Health .Care Administration and/or Substance Abuse and Mental Health Services Administration (SAMHSA) for specimen collection. E, Prior. to allowing the individual to enter the collection area, the collection site person shall examine the .area (restroom) as determined by the Agency for Health Care Services Administration (ARCA) and/or.Substance Abuse and Mental Health Services•Administration (SAMHSA) and shall verify that a water soluble colored dye is in the toilet if required. F. Instructions provided by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) shall be provided by the collection site person to the individual as to not .to flush the toilet until the specimen has been given to the collection site person, and it is deemed to be an acceptable sample. If applicable, the employee shall be told that if'the sound of' ng water is heard coming from within the restroom, by the collection site person, the individual shall be instructed to exit the restroom and informed that the sample, if any, does not meet the City of Miami guidelines. The sample shall e considered as adulterated, an will e taken into custody by the collection site person and retained for analysis. G. The individual shall enter the collection area (restroom), close the door for privacy and void into the container. The collection site person shall remain near the restroom facility (collection area), within audible range of the individual. H. The collection site person shall document any unusual behavior or appearance of the individual. 25 1. Upon receiving the specimen from the individual, the collection site person shall confirm that the applicant/employee has provided the required amount of urine as determined by Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). If the individual fails for any reason, to provide the required amount of urine, the procedure must be initiated from the beginning and the employee must be instructed not to leave the premises. After the specimen has been provided and submitted to the collection site person, the individual shall be allowed to wash his or her hands. K. Immediately after the specimen is collected, the collection site person, in the presence of the individual, shall inspect the specimen to determine the color and look for any signs of contaminants .as required by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration :(SAMHSA). L. Immediately upon receiving the specimen, the collection site person shall check the temperature sensitive label on the specimen cup to determine if it is at an acceptable temperature as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). If the specimen's temperature is not within the acceptable range, the proper testing reporting procedures should be followed in accordance with ARCA and/or SAMHSA guidelines. M. Guidelines established by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services (SAMHSA) should be followed if there is any suspicion of a specimen being adulterated.' NT. The donor should provide the amount of specimen required by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). N The collection site person shall place securely on the bottles the required identification label which as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services P. If required, the individual shall initial the evidence tape/identification label portion of the specimen bottles for the purpose of certifying that .they are the specimens collected from him or her. Q. The collection site person must place the specimens and chain of custody form in secure location as determined by the Agency for Health Care Administration 26 (AHCA) and/or Substance Abuse and Mental Health Services _Administration (SAMHSA). DRUG TESTING (LABORATORY FACILITY) QUALIFICATIONS/SERVICES Security and Chain of Custody The drug testing laboratory shall be secure at all times, Sufficient security measures to control access to the premises and to ensure that no unauthorized personnel handle Specimens or gain access to the laboratory processes or to areas where records are stored must be in place. Access to these secured areas shall be limited to specifically authorized individuals whose authorization is documented. Laboratories shall use chain of custody procedures to maintain control and accountability of specimens from receipt through completion of testing, reporting of results, during storage, and continuing until final disposition of specimens. The date and purpose shall be documented on an appropriate chain of custody form each, time a specimen is handled or transferred, and every individual in the chain shall be identified. Accordingly, authorized technicians shall be responsible for each urine specimen or aliquot in their possession and shall sign and complete chain of custody forms for those specimens or aliquots as they are received.: A. The laboratory must be licensed and approved by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration .(SAMHSA) using criteria established by the United .States Department of Health and Human Services as general guidelines for the City of .Miami's drug testing program. B. The provider must have a qualified individual as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) to review the standards, control specimens and quality control data together with the screening and confirmation test results; a licensed technologist supervisor and licensed technicians (all licensed by the State of Florida). A phlebotomist must be available to draw blood specimens; and a Breath Alcohol Technician (BAT) trained to proficiency in the federal alcohol testing. procedures must also:be available. C. All tests shall be conducted in a licensed facility operated by the provider or at such aci i subseque-n-tly agree the City and the provider. Laboralory facility must be currently licensed and approved by the Agency for Health Care Administration (AHCA) and/or. Substance Abuse and Mental Health Services Administration (SAMHSA). Laboratory must have the capability of performing drug screenings and GCMS confirmations at the same facility. 27 D. The provider's premises and equipment must have passed all inspections by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). E The provider's facility must have a quality assurance program which encompasses all aspects of the testing process: specimen acquisition, chain of custody security and -reporting results, in addition to the screening and confirmation of analytical procedures. Quality control procedures will be designed, implemented and reviewed to monitor the -conduct of each step of the process. The provider's facility must meet or exceed standards established by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental health Services Administration (SAMHSA). F. The provider must have experience in handling toxicology specimens (both urine and blood) and provide a well documented chain of custody for all tests as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA). G. The provider must have a procedures manual as determined by the Agency for Health Care Administration (ARCA) and/or :Substance Abuse and/or Mental Health Services Administration (SAMHSA) to ensure chain of custody. H. The provider must follow proper quality control procedures including, but not limited to the use of internal quality controls including the use of samples of known concentrations which are.used to check the performance and calibration of testing equipment, and periodic use of blind samples for overall accuracy; an internal review and certification process for drug test results, conducted by a personqualified to perform that function in the testing laboratory; security measures implemented by the testing laboratory to preclude adulteration of specimens and drug test results; and any other required steps to ensure reliable and accurate drug test results. I. The provider shall maintain documentation of all aspects of the testing process as determined. by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). The provider shall designate a who will be responsible for program coordination .and to provide a singe point m e < purchaser and the provider on all matters concerning the contract. K. The provider shall provide a written test result report to the City of Miami, Department of Employee Relations in accordance with the Agency for Health Care Administration (AHCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA). 28 MEDICAL REVIEW OFFICER (MRO) QUALIFICATIONS/SERVICES A. The Medical Review Officer (MRO) shall be certified as a Medical Review Officer in accordance with the Agency for Health Care Administration (AHCA) and/or Substance Abuse and. Mental Health Services Administration (SAMHSA) guidelines. & The MRO shall evaluate the drug test -result(s), which is reported out by the laboratory, in accordance with Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. C. If the MRO is unsuccessful in contacting an applicant/employee regarding drug or alcohol testing results, he/she is to contact the City of Miami, Department of Employee Relations at (305) 416-2100 for assistance in contacting the employee and expediting the reporting of results. D. The MRO shall notify the City of Miami, Department of Employee Relations at (305) 416-2100 immediately upon confirmation of a positive drug test result. Please .note that this Drug Screening Protocol is subject to revision and change. 29 CITY OF MIAMI DRUG SCREENING PROTOCOL Part V Services: Sworn Police Drug and AIcohol Screening Services (Raudonr and Reasonable Suspicion Testing) Pursuant to Article 34, of the FOP Labor Agreement, "in an effort to identify and eliminate on or off duty controlled substance abuse and on duty alcohol abuse, a bargaining unit member will be ordered to undergo a urinalysis/blood test immediately upon notification" as provided within Section 34.1 of the agreement. Throughout each calendar year the City may conduct up to one thousand two hundred and fifty (1,250) random substance screenings on members of the bargaining unit. The following drugs or classes of drugs and cut-off concentration levels.shall be applicable for determining whether specimens are negative or positive for the initial or confirmation test. A positive result shall be a concentration in excess of the following: Initial Test Level (ng/mI) GC/MS Level (na/ml) Cannabis (Marijuana) Metabolites .50 15 Cocaine Metabolites 300 150 Opiate Metabolites 2000 In accordance with levels specified by Department of Human Services Federal Register, Part III, dated April 13, 2004 Phencyclidine 25 25 Amphetamines 1000 500 Methaqualone "'- 300 150 Methadone Propoxyphene 300 150 Tricyclic Antidepressants 300 150 Ketamine* 25 Gamma-hydroxybutyrat* 150 A4ethylenedioxymethamphetamine (MDMA, Ecstasy) _. 300 , 150 30 * Ketamine and Gamma-hydroxybutyrate will be tested under reasonable belief in accordance with Article 34.1 and will not be included as part of the random substance screenings in accordance with Article 34.2. NOTE: These drug testing panels and concentrations are subject to revision with changes in convention or technology. The following guidelines have been established in conjunction with standards developed by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) and existing City of Miami departmental policies and procedures, as well as requirements set forth in the existing collective bargaining agreement: SPECIMEN COLLECTION SERVICES Chain of Custody A chain of study of custody standardized form shall be properly executed by authorized collection site personnel upon receipt . of specimen as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). Handling and transportation of urine and/or blood specimens from one authorized individual or place to another shall always - be accomplished through chain of custody procedures as determined by AHCA and/or SAMHSA. Every effort shall be made to minimize the number of persons handling specimens. 2. Integrity and Identity of Specimen Collection site personnel shall take precautions to ensure that a urine specimen not be adulterated or diluted during the collection procedure and that information on the urine bottle and chain of custody form can identify the.individual from whom the specimen was collected as per Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. The necessary precautions shall be taken to ensure that unadulterated specimens are obtained and correctly :identified as determined by AHCA and/or SAMHSA, as well as in addition to City ot Miami establishee policies and procedures. A. When an individual arrives at the collection site, the collection site person shall require the individual to present photo identification. If the individual's identity cannot be established, the collection site person shall not proceed with the collection until identity has been established. The Police Department must be notified immediately of those cases in which identity cannot be established. In those cases involving reasonable suspicion, employee must be escorted by a 31 supervisor, employee must present photo identification and specimen collection must be taken "under direct observation". B. Employees shall give either a blood sample, for suspected alcohol use or a urine sample for suspected substance abuse as determined by the City. The individual shall be instructed to wash and dry his or her hands prior to urination, if such facilities are available. The collection area shall meet the requirements determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). C. The individual shall remain in the presence of the collection site person and shall not have access to a water fountain, faucet, soap dispenser, cleaning agent or any other material which could be used to adulterate the specimen. Only one (1) individual shall be allowed inside the collection area (restroom) at any given time. The individual shall not be allowed to bring anything, including any smoking materials, into the collection area. The individual shall remove all unnecessary outer garments. All bags, packs, purses, etc., shall be left outside of the. collection area (restroom) secured in a locked unit. The individual may retain his or her wallet. D. The individual shall be given the necessary container(s) as determined by the Agency for Health Care Administration and/or Substance Abuse .and Mental Health Services Administration (SAMHSA) for specimen collection. E. Prior to allowing the individual to enter the collection area, the collection site person shall examine the area (restroom) as determined by the Agency for Health Care Services Administration (AHCA) andJor Substance Abuse and Mental Health Services Administration (SAMHSA) and shall verify that a water soluble colored dye is in the toilet if required. F. Instructions provided by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) shall be provided by the collection site person to the individual as to not to flush the toilet until the specimen has been given to the collection site person,. and it is deemed to be an acceptable sample. If applicable, the employee shall be told that if the ,sound -of running water is heard coming from within the restroom, by the collection site person, the individual shall be instructed to exit the restroom and informed mate same eif any, not meet re r o rani gur ernes. e sample shall be considered as adulterated, and will be. taken into custody by the collection site person and retained for analysis. G. The individual shall enter the collection area (restroom), close the door for privacy and void into the container. The collection site person shall remain near the restroom facility (collection* area), within audible range of the individual. 32 H. The collection site person shall document any unusual behavior or appearance of the individual. 33 Upon receiving the specimen from the individual, the collection site person shall confirm that the applicant/employee has provided the required amount of urine as determined by Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). If the individual fails for any reason, to provide the required amount of urine, the procedure must be initiated from the beginning and the employee must be instructed not to leave the premises. J. After the specimen has been provided and submitted to the collection site person, the individual shall be allowed to wash his or her hands. K. Immediately after the specimen is collected, the collection site person, in the presence of the individual, shall inspect the specimen to deterinine. the color and look for any signs of contaminants as required by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). L. Immediately upon receiving the specimen, the collection site person shall check the temperature sensitive label on the specimen cup to determine if it is -at- an acceptable temperature as determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA)'. • If the specimen'_s temperature is not within the acceptable range, the proper testing reporting procedures should be followed in accordance with AHCA and/or SAMHSA guidelines. M. Guidelines established by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services (SAMHSA) should be followed if there is any suspicion of a specimen being adulterated. N. The donor should provide the amount of specimen required by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). 0. The collection site person shall place securely on the bottles the required identification label which as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services rnrs ra ion P. If required, the individual shall initial the evidence tape/identification label portion of the specimen bottles for the purpose of certifying that they are the specimens collected from him or her. Q. The collection site person must place the specimens and chain of custody form in secure location as determined by the Agency for Health Care Administration 34 (ARCA) and/or Substance .Abuse and Mental Health Services Administration (SAMHSA). DRUG TESTING (LABORATORY FACILITY) QUALIFICATIONS/SERVICIES Security and Chain of Custody The drug testing laboratory shall be secure at all times. Sufficient security measures to control access to the premises and to ensure that no unauthorized personnel handle specimens or gain access to the laboratory processes or to areas where records are stored must be in place. Access to these secured areas shall be limited to ,specifically authorized individuals whose authorization is documented. Laboratories shall use chain of custody procedures to maintain control and accountability of specimens from receipt through completion of testing, reporting of results, during storage, and continuing until final disposition of specimens. The date and purpose shall be documented on an appropriate chain of custody form each time a specimen is handled or transferred, and every individual in the chain shall be identified. Accordingly, authorized technicians shall be responsible for each urine specimen or aliquot in their possession and shall sign and complete chain of custody forms for those specimens or aliquots as they are received;, A. The laboratory must be licensed and approved by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) ; using . criteria established by the United States Department of Health and Human Services as general guidelines for the City of Miami's drug testing program. B. The provider must have a qualified individual as _determined by the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) to review the standards, control specimens and quality control data together with the screening and confirmation test results; a licensed technologist supervisor and licensed technicians (all licensed by the State of Florida). A phlebotomist must be available to draw blood specimens; and a Breath Alcohol Technician (BAT) trained to proficiency in the federal alcohol testing procedures must also be available. C. All tests shall be conducted in a licensed facility operated by the provider or at such aci i su sequen ly agreed facility roust be currently licensed and approved by the Agency for Health Care Administration (ARCA) acid/or Substance Abuse and Mental Health Services Administration (SAMHSA). Laboratory must have the capability of performing drug screenings and GCMS confirmations at the same facility. 35 D. The provider's premises and equipment must have passed all inspections by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and Mental Health Services Admiriisiiation (SAMHSA). E. The provider's facility must have a quality assurance program which encompasses all aspects of the testing process: specimen acquisition, chain of custody security and reporting results, in addition to the screening and confirmation of analytical procedures.' Quality control procedures will be designed, implemented and reviewed to monitor the conduct of each step of the process. The provider's facility must meet or exceed standards established by the Agency for Health Care Administration _(AHCA) and/or 'Substance Abuse and Mental Health Services Administration (SAMHSA). F. The provider must have experience in handling toxicology specimens (both urine and blood) and provide a well documented chain of custody for all tests as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA). G. The provider must have a procedures manual as determined by the Agency for Health Care Administration (AHCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA) to ensure chain of custody. H. , The provider must follow proper quality control procedures including, but not limited to the use of internal quality controls .including the use of samples of known concentrations which are used to check the performance and calibration of testing equipment, and periodic use of blind samples for overall accuracy; an internal review and certification process for drug ' test results, conducted by a person qualified to perform that function in the testing laboratory; security measures implemented by the testing laboratory to preclude adulteration of specimens and drug test results; and any other required steps to ensure reliable and accurate drug test results. I. The provider shall maintain documentation of all aspects of the testing process as determined by the Agency for Health Care Administration (AFICA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA). designatej. The provider shall program will — program coordination and to provide a single point interface between the purchaser and the provider on all matters concerning the contract. K. The provider shall provide a written test result report to the City of Miami, Department of Police in accordance with the Agency for Health Care Administration (AHCA) and/or Substance Abuse and/or Mental Health Services Administration (SAMHSA). 36 MEDICAL REVIEW OFFICER (MRO) QUALIFICATIONS/SERVICES A. The Medical Review Officer (MRO) shall be certified as a Medical Review Officer in accordance with the Agency for Health Care Administration (ARCA) and/or Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. B. The MRO shall evaluate the drug test result(s), which is reported out by the laboratory, in accordance with Agency for Health Care Administration (ARCA) and/or :Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. C. If the MRO is unsuccessful in contacting an applicant/employee regarding drug or alcohol testing results, he/she is to contact the City of Miami, Department of Police for assistance in contacting the employee and expediting the reporting of results. D. The MRO shall notify the Police bargaining unit member of a positive result. Notice to the bargaining unit member of the test being positive shall be considered to have been served upon the bargaining unit member by the MRO upon oral communication. Please note that this Drug Screening P'rotoc'ol is subject to revision and change. 37 i OUtpatient CQnt¢e February 5, 2009 City of Miami ATTN: Ana T. Cobelo Administrative Assistant II Department of Employee Relations Dear Ms. Cobelo, Attachment "B" This letter is a follow-up to our telephone conversation today concerning the drug screening services provided to the City of Miami by Mercy Medical Development d1b/a Mercy Outpatient Center. 1 am confirming that the charge of $25.00 for Urine Drug Screen with Chain of Custody and the charge of $25.00 for Blood Alcohol Level Test and Chain of Custody includes the specimen collection. There is no additional charge for the specimen collection. Please see the attached fee schedule for Parts I, 11, and IV. Please feel free to contact me at 305-285-2981 or email at ariberoCalmercymiami.org if you need any.further information. Sincerely, Alfonso E. Ribero Director of Laboratory Services Line: I. Description: Part I Services - A. Collection Facility Line: 1.1 Description: Urine specimen collection with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $_ N.n Charge Number of Units: 600 Total: S Line: 1.2 Description: Blood.Alcohol Level collection with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $ Nn Qh arge Number of Units: 10 Total: , N L A Line: 1.3 Description: Next day delivery to Testing Facility with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $LA _ Number of Units: 600 Total: $ N/A Line: 1.4 Description: Additional Charges necessary (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this Iine. However, Proposer is required to etai'in their proposal response what those additional fees are. Category: 95207-00 Unit of Measure: Each Unit Price: $AA Number of Units: Total: $-N/ A Page 5 of 78 Line: 2 Description: Part 1 Services - B. Drug Testing Facility Line: 2.1 Description: Urine Drug Screen (11 Drug Panel) with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $ .7•� .. _._..:. __ .. Number -of Units: -600 .. .-Total:. $1 5 0 Q Line: 2.2 Description: Blood AIcohol Level Test with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $ 2 Number of Units: 10 Total: $ 2 5 0 Line: 2.3 Description: GCMS Confirmation with Chain of Custody Category,. 95207-00 Unit of Measure: Each Unit Price: $included Number of Units: 50 Total: $Included Description: Additional Charges necessary (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this line. However, Proposer is required to detail in their proposal response what those additional fees are, Category: 952D7- 00 Unit of Measure: Each Page 6 of 78 Unit Price: $ N/A Number of Units: Total: $—N /A Line: 3 Description: Part I Services -- C. Medical Review Officer (MRO) Services Line: 3.1 Description: Medical Review Officer -_.._..Category-:9MV..-0.0._.... Unit of Measure: Each Unit Price: $Tnc-1 udeB Number of Units: 600 Total: $ T _Q d Line: 3.2 Description: Additional Charges necessary (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this line. However, Proposer is required to detail In their proposal response what those additional fees are. Category: 95207=00 Unit of Measure: Each Unit Price: $kLIA Number of Units: Total: $ N/A Line: 4 Description: Part II Services - A. Collection Facility Line: 4.1 Description: Urine specimen collection with Chain of Custody (11 Drug Panel) Unit of Measure: Each Unit Price: $ jo-ch.�rge Number of Units: 400 Total: $ / A Page 7 of 78 Line: 4.2 Description: Blood Alcohol Level collection with Chain of Custody •Category.: 9520740 Unit of Measure: Each Unit Price: $ Nn ('barge Number of Units: 15 Total: $; N/A Line: 4.3 .......Description:-Next;day..delivery__to.Testing.F-acility.with.Chain.of-Custody- -- .. - -• Category: 95207-00 Unit of Measure: Each Unit Price: $Ilj A Number of Units: 400 Total: $-N /A Line: 4.4 Description: After Hour Service Category: 95207-00 Unit of Measure: Each Unit Price: $ N /A Number of Units: 15 Total: $ N/A Line: 4.5 Description: Additional Charges necessary (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this line. However, Proposer is required to detail in their proposal response what those additional fees are. Category.: 95207-00 Unit ofMeasurev Each Unit Price: $ � A Number of Units: Total: $ N / A l Line:5 Page 8 of 78 Description: Part 1f Services - B. Drug Testing Facility Line: 5.1 Description: Urine Drug Screen (11 Drug Panel) with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $25 Number of Units: 400 Total: $ 10 000 Line: 5.2 Description: Blood Alcohol Level Test with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $25 Number of Units: 15 Line: 53 Description: GCMS Confirmation with Chain of Custody Category: 95707-00 Unit of Measure: Each Unit Price: $3nc1uded Number of Units: 50 Total: $-3 7 5 Total: $ Included Line: 5.4 Description: Consultation and Testimony '{ a egory: Unit of Measure: Hour Unit Price: $ Nn C a rge Number of Units: 50 Total: $ N A Page 9 of 78 Line: 5.5 Description: Additional Charges necessary (if any) to tricet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this line. However, Proposer is required to detail in their proposal response what those additional fees are. Category: 95207-00 Unit of Measure: Each. Unit Price: $AICA -- Number of Units: Total: $411t-- Line: 6 Description: Part iI Services - C. Medical Review (MRO) Services Line: 6.1 Description: Medical Review Officer Category: 95207-00 Unit of Measure: Each Unit Price: �. Line: 6.2 Number of Units: 400 Total: Description: Additional Charges necessary (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this line. However, Proposer Is required to detail in .their proposal response what those additional fees are. Category: 95207-00 Unit of Measure: Each Unit Price:_ Number of Units: Total: $N Line- 7 Description: Part III Services -A. Collection FacIIity Line: 7.1' Description: Urine specimen collection with Chain of Custody (SAMHSA Drug Panel) Page 10 of 78 Line: 10 Description: Part IV Services - A. Collection Facility Line: 10.1 Description: Urine specimen collection with Chain of Custody (11 Drug Panel) Category: 9.5207-00 Unit of Measure: Each Unit Price; $_.�o Ch�ge Number of Units: 300 Total: u - N /A J Line: 10.2 Description: Evidential Breath Testing Category: '95207-00 Unit of Measure: Each Unit Price.$ N /A Number of Units: 150 Total: $-.-,� Line: 10.3 Description: Next day delivery to Testing Facility with Chain of Custody Category. 95207-00 Unitof Each Unit Price: $N1 A Number of Units: .300 Total: $ NJ A Line: 10.4 Description: After Hour Service Category. 95207-00 Unit of Measure: Each Unit Price: $N f p Number of Units: 50 Total: $ N/A Page 14 of 79 Line: 10.5 Description: Additional Charges necessary (it any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this line. However, Proposer is required to detail in their proposal response what those additional fees are. Category: 95207-00 Unit of Measure: Each Unit Price: $ / p Number of Units: Total: $ N l A Line: 11 . Description: Part IV Services - B..Drug Testing Facility Line: 11.1 Description: Urine Drug Screen with Chain of Custody (SAMHSA Drug Panel) Category: 95207-00 Unit of Measure: Each Unit Price: $ .2 5 Number of Units: 300 Line: 11.2 Description: Evidential Breath Testing Category: 95207-00 Unit of Measure: Each Unit Price: $2 5 Number of Units: 150 Line: 11.3 Description: GCMS Confirmation with Chain of Custody Category: 95207-00 Unit of Measure: Each Total: $ 7,500 Total: $ 3,750 Page 15 of 78 . Unit Price: $ Included Number of Units: 50 Total: $ Included Line: 11.4 Description: Consultation and Testimony Category: 95207-00 Unit of Measure: Hntw Unit Price: $ PDQCharge -Number of Units: 10 Total: $ 15 , 00.0 Line: 11.5 Description: Additional Charges necessary. (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this tine. However, Proposer is required to detail in their proposal response what those additional fees are. Category: 95207-00 Unit of Measure: Each Unit Price: $ N A Number of Units: Total: $ NSA Line: 12 Description: Part IV Services - C. Medical Review Officer (MRO) Services Line: 12.1 Description: Medical Review Officer Category: 95207-00 Unit of Measure: Each Unit Price: $_Included Number'of Units: 300 Total: $ Included Line: 12.2 Description: Additional Charges necessary (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges .in this line. i However, Proposer is required to detail in their proposal response what those additional fees are. Page 16 of 78 Category. 95207-00 Unit of Measure: Each Unit Price: $N j A Number of Units: Line: 13 A Description: Part V Services- A. Collection Facility Line:.13.1 Descriptio .L-Urin"ptdmsn_cnileetion with_Chain_oLCustody. Category: 95207-00 Unit of Measure: Each Unit Price: $ Number of Units: 1,250 Total: N A Total: S Line: 13.2 Description: Blood AIcohol Level collection with Chain of Custody . Category: 95207-00 Unit of Measure: Each Unit Price: $_ Number of Units: 15 Total: $„ Lirie: 13.3 Description: Next day delivery to Testing Facility with Chain of Custody Category: 95207-00. Unit of Measure: Each - - - urn er-o - ruts. -0 Line: 13.4 Page 17 of 78 Description: After Hour Service Category: 95207-00 Unit of Measure: Each Unit Price: $— NZA Line: 13.5 Number of Units: 400 Total: $ N / A Description: Additional Charges necessary (if any) to meet the terms of the RFP Proposer is only required to enter the total amount of the additional charges in this line. However, Proposer is required to detail in their proposal response what those additional fees are. Category: 95207-00 Unit of Measure: Each Unit Price: $ N A Number of Units: Total: $ N /A Line: 14 Description: Part V Services - B. Drug Testing Facility Line: 14.1 Description: Urine Drug Screen with Chain of Custody (12 Drug Panel) Category: 95207-00 Unit of Measure: Each Unit Price: $ 2 5 Number of Units: 1,250 Total: $ 1 z 5 p Line: 14.2 Description: Blood Alcohol Level Test with Chain of Custody Category: 95207-00 Unit of Measure: Each Unit Price: $ 2 5 Number of Units: 15 Total: $ -17 5 Page 18 of 78 -Ou a KI Cient ¢nt¢r February 12, 2009 City of Miami ATTN: Glenn Marcos, CPPD, CPPB, FCPM, FCPA Chief Procurement Officer Department of Purchasing P.O. Box 330708 Miami, Florida 33233-0708 RE: RFP No. 1.05049 Dear Mr. Marcos, This letter is a follow-up to our telephone conversation today concerning the proposal for drug screening services to the City of Miami by Mercy Medical Development .d/b/a Mercy Outpatient Center. Mercy Outpatient Center would like very much to be reconsidered as responsive for Part V, Sworn Police Officers Drug Screening Services (.Random and Reasonable Suspicion Testing). In order to comply with the requirement of providing a self contained mobile unit, Mercy Outpatient Center will rent a free standing RV unit for use in specimen collection When requested to do so by the client. Please see the attached fee schedule for Part V. Please feel free to contact me at 305-285-2981 or email at aribero(cb,mercymiami.org if you need any further information. Sincerely, r - AI onso E. Ribero Director of Laboratory Services